Alior Bank S.A. (WSE:ALR)

Aerovate Therapeutics Cash Flow Statement

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	2,398	2,445	2,030	683.11	481.93	-311.23
Depreciation & Amortization	174.09	172.31	173.03	165.14	169.43	174.81
Other Amortization	98.14	98.14	85.74	76.88	63.55	112.85
Gain (Loss) on Sale of Assets	-	-	-	-	0	0.05
Total Asset Writedown	1.17	1.73	4.91	52.39	10.48	132.78
Change in Trading Asset Securities	-3,384	-5,612	-5,384	-844.2	-2,113	3,208
Change in Other Net Operating Assets	106.71	-1,312	-4,258	866.41	-4,501	-5,159
Other Operating Activities	-362.7	-205.61	-61.73	242.06	179.2	-93.86
Operating Cash Flow	-968.97	-4,412	-7,411	1,242	-5,710	-1,935
Capital Expenditures	-71.85	-90.46	-94.86	-103.18	-127.88	-93.37
Sale of Property, Plant and Equipment	19.6	12.55	20.18	17.92	4.85	8.87
Investment in Securities	-656.59	762.26	3,844	-179.91	1,873	-
Divestitures	-	-	-	-	5.33	-
Purchase / Sale of Intangibles	-92.38	-98.9	-74.76	-46.57	-53.5	-53.94
Investing Cash Flow	-801.21	585.45	3,695	-311.74	1,701	-138.43
Long-Term Debt Issued	-	950	851.86	-	-	-
Long-Term Debt Repaid	-	-1,218	-79.6	-281.52	-534.34	-74.1
Net Debt Issued (Repaid)	-428.08	-267.57	772.26	-281.52	-534.34	-74.1
Net Increase (Decrease) in Deposit Accounts	5,827	3,857	3,023	-1,746	5,904	3,311
Other Financing Activities	-175.88	-178.15	-124.88	-81.55	-57.57	-82.68
Financing Cash Flow	5,223	3,411	3,671	-2,109	5,312	3,155
Net Cash Flow	3,452	-415.91	-44.88	-1,179	1,303	1,081
Free Cash Flow	-1,041	-4,503	-7,505	1,139	-5,838	-2,029
Free Cash Flow Margin	-18.25%	-79.61%	-149.90%	33.35%	-216.85%	-104.26%
Free Cash Flow Per Share	-7.97	-34.49	-57.49	8.72	-44.71	-15.54
Cash Interest Paid	2,090	2,330	2,801	1,413	365.06	882.86
Cash Income Tax Paid	598.66	595.23	369.17	110.98	119.77	205.66

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.